Detecting the "undetectable" alterations: Use of NGS to uncover high-risk alterations

Chelsea Halprin1, Sumire Kitahara1, Eric Vail1

  • 1Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, United States.

Cancer Genetics
|March 6, 2022
PubMed